Meniscus Repair Does Not Result in an Inferior Short-term Outcome Compared With Meniscus Resection: An Analysis of 5,378 Patients With Primary Anterior Cruciate Ligament Reconstruction.


Journal

Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association
ISSN: 1526-3231
Titre abrégé: Arthroscopy
Pays: United States
ID NLM: 8506498

Informations de publication

Date de publication:
04 2020
Historique:
received: 06 06 2019
revised: 06 11 2019
accepted: 17 11 2019
pubmed: 8 12 2019
medline: 26 11 2020
entrez: 8 12 2019
Statut: ppublish

Résumé

To compare the preoperative and 1- and 2-year postoperative Knee Injury and Osteoarthritis Outcome Score (KOOS) subscale scores between isolated anterior cruciate ligament reconstruction (ACLR) and ACLR with additional medial meniscus (MM) and/or lateral meniscus (LM) resection or repair. A total of 5,378 patients who underwent primary ACLR, with no associated ligament injuries, at our institution from January 2005 to December 2015 were included. The KOOS subscale scores were used to evaluate patients preoperatively and at 1- and 2-year postoperative follow-up assessments. Patients who underwent isolated ACLR and those who underwent ACLR with additional MM resection, MM repair, LM resection, LM repair, MM plus LM resection, or MM plus LM repair were compared by use of an analysis of covariance, with age, sex, graft, and cartilage injury as covariates. Postoperatively, at both 1- and 2-year follow-up assessments, no significant differences were found between the groups for any of the 5 KOOS subscales. Preoperatively, a significant difference between the groups was found for the KOOS Symptoms (P < .001), Pain (P < .001), Activities of Daily Living (ADL) (P < .001), and Sport and Recreation (Sport/Rec) (P = .01) subscale scores. The lowest scores were found for the group undergoing ACLR and MM plus LM repair (Symptoms, 70.1 ± 17.3; Pain, 71.4 ± 18.5; ADL, 80.6 ± 20.5; and Sport/Rec, 35.7 ± 28.1), whereas the mean scores for the other groups ranged from 71.2 ± 18.7 to 76.5 ± 17.1 for Symptoms, from 76.1 ± 17.0 to 80.1 ± 15.5 for Pain, from 84.5 ± 16.8 to 88.1 ± 14.2 for ADL, and from 44.2 ± 28.3 to 49.1 ± 28.5 for Sport/Rec. Patients undergoing isolated ACLR and those undergoing ACLR with additional MM and/or LM resection or repair obtained equivalent results for each of the KOOS subscales at the 1- and 2-year postoperative follow-up assessments. Differences between the groups were only detectable preoperatively, with patients undergoing ACLR and MM plus LM repair showing the lowest scores for the KOOS Symptoms, Pain, ADL, and Sport/Rec subscales. Level III, retrospective comparative therapeutic trial.

Identifiants

pubmed: 31811890
pii: S0749-8063(19)31165-X
doi: 10.1016/j.arthro.2019.11.124
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1145-1153

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.

Auteurs

Riccardo Cristiani (R)

Capio Artro Clinic, Department of Molecular Medicine and Surgery, Stockholm Sports Trauma Research Center, Karolinska Institutet, Stockholm, Sweden. Electronic address: riccardo.cristiani87@gmail.com.

Andreas Parling (A)

Faculty of Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Magnus Forssblad (M)

Department of Molecular Medicine and Surgery, Stockholm Sports Trauma Research Center, Karolinska Institutet, Stockholm, Sweden.

Gunnar Edman (G)

Department of Molecular Medicine and Surgery, Stockholm Sports Trauma Research Center, Karolinska Institutet, Stockholm, Sweden.

Björn Engström (B)

Capio Artro Clinic, Department of Molecular Medicine and Surgery, Stockholm Sports Trauma Research Center, Karolinska Institutet, Stockholm, Sweden.

Anders Stålman (A)

Capio Artro Clinic, Department of Molecular Medicine and Surgery, Stockholm Sports Trauma Research Center, Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH